Asia-Pacific women health diagnostics market is growing at a CAGR of approximately 9.7% during the forecast period. The Asia-Pacific is one of the developed economies of the world, according to World Bank, the GDP of Asia-Pacific is around $24.5 trillion in the year 2018, which indicates huge growth opportunities for the multinational players to invest. Increasing health infrastructure in developing countries such as China and India is estimated to fuel the growth of the women health diagnostic market. One of the major reasons for the growth of the GDP of APAC is remittance received from foreign nations.

A full report of Asia-Pacific Women Health Diagnostics Market is available at:   https://www.omrglobal.com/industry-reports/asia-pacific-women-health-diagnostics-market

Further, increasing incidences of the CVD among women in the Asia Pacific region is estimated to be the major factor that is contributing significantly towards the growth of the Asia-Pacific women health diagnostics market. Cardiovascular diseases have become a major health threat in the Asia Pacific region. It was estimated that non-communicable cardiovascular diseases account for 7 out of 10 fatalities in developing countries. Moreover, increasing incidences of breast cancer in the Asia Pacific region is also augmenting the demand of the Asia-Pacific women health diagnostics market. Breast cancer has emerged as a major health issue in the Asia-Pacific region. Australia is estimated to have the highest rate of breast cancer incidences in the APAC region. Obesity, alcohol consumption and smoking are some of the major factors that are backing the increasing prevalence of breast cancer in Australia.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/asia-pacific-women-health-diagnostics-market

In addition, the declining fertility rate in the Asia Pacific region is also one of the major factors that are driving the growth of the Asia-Pacific women health diagnostics. Over the last decade, a decline in fertility rates in the Asia Pacific region has been witnessed. Urbanization and changing lifestyle is one of the major factors that are responsible for infertility. Lifestyle factors such as alcohol, smoking, caffeine, stress, weight are the major factors that affect the fertility.

Asia-Pacific Women Health Diagnostics Market- Segmentation

by Applications
  • Breast Cancer Testing
  • Cervical Cancer Testing
  • Pregnancy & Fertility Testing
  • Ovarian Cancer Testing
  • Infectious Disease Testing
  • Ultrasound Tests
  • Sexually Transmitted Disease Testing
  • Others (Osteoporosis Testing and Prenatal Genetic Testing)
by End-User
  • Diagnostic and Imaging Centers
  • Hospitals and Clinics
  • Home Care
Visit for Global Women Health Diagnostics Market Report at:  https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size

Asia-Pacific Women Health Diagnostics Market – Segment by Region
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
Company Profiles
  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Luminex Corp.
  • Siemens AG
  • Somagen Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research


Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

0 Comments